The website is an attempt to simplify access to women’s health research for clinicians, patients and the public.

GCC-4001 is a cell therapy commercialized by Artiva Biotherapeutics, with a leading Phase II program in B-Cell Non-Hodgkin Lymphoma.

It strives to develop products for the treatment of neurology and immunology related conditions. The company’s marketed products include Cimzia for ankylosing spondylitis, axial spondyloarthritis, ...

Chandigarh: The government-run Panchkarma Centre in Sector 37 has reported a significant increase in patient visits, ...